Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Cardiol Therapeutics Inc’s stock clocked out at $1.08, up 0.93% from its previous closing price of $1.07. In other words, the price has increased by $0.93 from its previous closing price. On the day, 0.75 million shares were traded. CRDL stock price reached its highest trading level at $1.0899 during the session, while it also had its lowest trading level at $1.055.
Ratios:
To gain a deeper understanding of CRDL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 02, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
On June 26, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $10.ROTH MKM initiated its Buy rating on June 26, 2024, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDL now has a Market Capitalization of 90427808 and an Enterprise Value of 72375304.
Stock Price History:
The Beta on a monthly basis for CRDL is 0.96, which has changed by -0.44897962 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, CRDL has reached a high of $2.24, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is -6.21%, while the 200-Day Moving Average is calculated to be -10.28%.
Shares Statistics:
It appears that CRDL traded 868.49K shares on average per day over the past three months and 925510 shares per day over the past ten days. A total of 82.67M shares are outstanding, with a floating share count of 79.63M. Insiders hold about 4.90% of the company’s shares, while institutions hold 7.80% stake in the company. Shares short for CRDL as of 1757894400 were 2192624 with a Short Ratio of 2.52, compared to 1755216000 on 1867823. Therefore, it implies a Short% of Shares Outstanding of 2192624 and a Short% of Float of 2.7199999999999998.
Earnings Estimates
The performance of Cardiol Therapeutics Inc (CRDL) in the stock market is under the watchful eye of 2 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.41 and -$0.42 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.37, with 3.0 analysts recommending between -$0.3 and -$0.42.
